NYSEArca - Delayed Quote USD

SPDR S&P Regional Banking ETF (KRE)

54.72 +0.13 (+0.24%)
At close: 4:00 PM EDT
54.69 -0.03 (-0.05%)
After hours: 5:25 PM EDT
Loading Chart for KRE
DELL
  • Previous Close 54.59
  • Open 54.23
  • Bid 54.72 x 3000
  • Ask 54.76 x 2200
  • Day's Range 53.89 - 54.87
  • 52 Week Range 37.66 - 59.59
  • Volume 8,075,049
  • Avg. Volume 15,022,054
  • Net Assets 3.44B
  • NAV 54.60
  • PE Ratio (TTM) 9.73
  • Yield 2.73%
  • YTD Daily Total Return 6.53%
  • Beta (5Y Monthly) 0.95
  • Expense Ratio (net) 0.35%

In seeking to track the performance of the S&P Regional Banks Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the regional banks segment of the S&P Total Market Index ("S&P TMI").

SPDR State Street Global Advisors

Fund Family

Financial

Fund Category

3.44B

Net Assets

2006-06-19

Inception Date

Performance Overview: KRE

View More

Trailing returns as of 10/2/2024. Category is Financial.

YTD Return

KRE
6.53%
Category
17.06%
 

1-Year Return

KRE
38.27%
Category
32.83%
 

3-Year Return

KRE
4.95%
Category
4.53%
 

People Also Watch

Holdings: KRE

View More

Top 10 Holdings (22.64% of Total Assets)

SymbolCompany% Assets
WAL
Western Alliance Bancorporation 2.47%
COLB
Columbia Banking System, Inc. 2.43%
VLY
Valley National Bancorp 2.36%
CFG
Citizens Financial Group, Inc. 2.24%
SNV
Synovus Financial Corp. 2.24%
RF
Regions Financial Corporation 2.23%
TFC
Truist Financial Corporation 2.23%
ZION
Zions Bancorporation, National Association 2.16%
EWBC
East West Bancorp, Inc. 2.15%
MTB
M&T Bank Corporation 2.15%

Sector Weightings

SectorKRE
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%
Healthcare   0.00%

Recent News: KRE

View More

Research Reports: KRE

View More
  • BUY on regulatory advancements and higher guidance

    Biogen is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases. The company is the market leader in multiple sclerosis drugs and launched the first approved treatments for spinal muscular atrophy and Alzheimer's disease. The company also sells products that treat plaque psoriasis, non-Hodgkin's lymphoma, lymphocytic leukemia, and rheumatoid arthritis. Current research continues on MS and has expanded to include neuroimmunology, ophthalmology, lupus, and other neuromuscular and movement disorders. Founded in 1978, the company is located in Cambridge, Massachusetts, employs 7,570 people, and is a component of the S&P 500.

    Rating
    Price Target
     
  • U.S. stock indices are mostly in the red today, with investors perhaps

    U.S. stock indices are mostly in the red today, with investors perhaps experiencing a little 'green exhaustion' after the solid gains booked of late. Also of note, the meaningful news starts to hit the tape tomorrow with the release of the Fed minutes, so getting a little defensive in case the minutes include unwanted news is also defensible.

     
  • Netflix Earnings: Fantastic Period Dampened by Likelihood of Growth Deceleration

    Netflix’s relatively simple business model involves only one business, its streaming service. It has the biggest television entertainment subscriber base in both the United States and the collective international market, with almost 250 million subscribers globally. Netflix has exposure to nearly the entire global population outside of China. The firm has traditionally avoided live programming or sports content, instead focusing on on-demand access to episodic television, movies, and documentaries. The firm recently began introducing ad-supported subscription plans, giving the firm exposure to the advertising market in addition to the subscription fees that have historically accounted for nearly all its revenue.

    Rating
    Price Target
     
  • Airbnb Earnings: Solid Demand and Profitability Set to Continue in 2024; Shares a Touch Rich

    Started in 2008, Airbnb is the world’s largest online alternative accommodation travel agency, also offering booking services for boutique hotels and experiences. Airbnb’s platform offered over 7 million active accommodation listings as of Sept. 30, 2023. Listings from the company’s over 4 million hosts are spread over almost every country in the world. In the fourth quarter of 2022, 47% of revenue was from the North American region. Transaction fees for online bookings account for all its revenue.

    Rating
    Price Target
     

Related Tickers